Company Name: |
Taizhou Crene Biotechnology Co. Ltd.
|
Tel: |
+86-0576-88813233 +86-13396860566 |
Email: |
sales@pharm-intermediates.com |
Products Intro: |
Product Name:Iralukast(CGP 45715A) CAS:151581-24-7 Purity:98% Package:10MG;100MG;500MG;1G
|
Company Name: |
Jinan ponder chemical co. LTD
|
Tel: |
0531-0000 |
Email: |
thinklifescience@163.com |
Products Intro: |
Product Name:151581-24-7 CAS:151581-24-7 Purity:99% HPLC Package:1KG;500G;100G;50G;1G
|
|
| IRALUKAST Basic information |
Product Name: | IRALUKAST | Synonyms: | Iralukast [inn];Unii-L1E28E0J8f;7-[(2S,3E,5Z)-10-(4-Acetyl-3-Hydroxy-2-Propylphenoxy)-1-Hydroxy-1-[3-(Trifluoromethyl)Phenyl]Deca-3,5-Dien-2-Yl]Sulfanyl-4-Oxochromene-2-Carboxylic Acid;4H-1-Benzopyran-2-carboxylic acid, 7-[[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(R)-hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadien-1-yl]thio]-4-oxo-;Iralukast (CGP 45715A) | CAS: | 151581-24-7 | MF: | C38H37F3O8S | MW: | 710.76 | EINECS: | | Product Categories: | | Mol File: | 151581-24-7.mol |  |
| IRALUKAST Chemical Properties |
storage temp. | Store at -20°C | solubility | Soluble in DMSO |
| IRALUKAST Usage And Synthesis |
Uses | Iralukast is a cysteinyl-leukotriene antagonist (CysLT) with a pKi of 7.8 for CysLT1. | IC 50 | CysLT1: 7.8 (pKi) | References | [1] Magnus B?ck, et al. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol. 2014 Aug; 171(15): 3551–3574. DOI:10.1111/bph.12665 [2] Valérie Capra, et al. Pharmacological characterization of the cysteinyl-leukotrieneantagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro.Br J Pharmacol. 1998 Feb; 123(3): 590–598. DOI:10.1038/sj.bjp.0701636 |
| IRALUKAST Preparation Products And Raw materials |
|